PFIZER INC.

The BRACELET-1 trial demonstrated that pelareorep combined with paclitaxel achieved a 31% objective response rate and 12.1-month median progression-free survival in HR+ HER2- metastatic breast cancer patients.

Perceptive Discovery announced the launch of the FIBRE Consortium, a pre-competitive collaboration with Pfizer, Lantheus, and Lumina Pharmaceuticals to revolutionize multi-organ fibrotic disease treatment through advanced imaging biomarkers.

Avalo Therapeutics has appointed Rita Jain, M.D., a rheumatologist with over two decades of biopharmaceutical leadership experience, to its Board of Directors.

UCLA Health researchers analyzed 3,500 hospitalized COVID-19 patients and found unvaccinated individuals were 16% more likely to require continuous renal replacement therapy during hospitalization.

A new comprehensive report analyzes 943 autoimmune collaboration and licensing deals from 2016-2025, covering over 30 diseases including multiple sclerosis, rheumatoid arthritis, lupus, and Crohn's disease.

BioNTech announced a $1.25 billion all-stock acquisition of CureVac through a public exchange offer, offering $5.46 per CureVac share representing a 55% premium to strengthen its mRNA-based cancer immunotherapy capabilities.

AstriVax Therapeutics has appointed Dieter Weinand, former CEO of Bayer Pharma with over 25 years of pharmaceutical industry experience, as Chair of the Board of Directors effective June 12, 2025.

Health Secretary Robert F. Kennedy Jr. has replaced all 17 members of the CDC's Advisory Committee on Immunization Practices with eight new appointees, significantly downsizing the committee.

The NRG-BR003 phase 3 trial found that adding carboplatin to standard paclitaxel and doxorubicin/cyclophosphamide chemotherapy did not provide statistically significant improvements in survival outcomes for triple-negative breast cancer patients.

The Trump administration canceled $766 million in federal contracts to develop mRNA vaccines against pandemic flu viruses, including Moderna's H5N1 bird flu vaccine program.